A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma-Reference-Cited by-同舟云学术

A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma

Published:2018-10 Issue:10 Volume:41 Page:1008-1014
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Hou Jian,Qiu Lugui,Zhao Yaozhong,Zhang Xuejun,Liu Yan,Wang Zhao,Zhou Fang,Leng Yun,Yang Shifang,Xi Hao,Wang Fuxu,Zhu Bing,Chen Wenming,Wei Peng,Zheng Xiangjun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference16 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family;Pitti;J Biol Chem,1996

3. Identification and characterization of a new member of the TNF family that induces apoptosis;Wiley;Immunity,1995

4. TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells;Gazitt;Leukemia,1999

5. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance;Kaufmann;Oncogene,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple mechanisms contribute to acquired TRAIL resistance in multiple myeloma;Cancer Cell International;2024-08-05

2. Multiple Mechanisms Contribute to Acquired TRAIL Resistance in Multiple Myeloma;2024-05-10

3. Aponermin: First Approval;Drugs;2024-03-05

4. Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial;BMC Cancer;2023-10-14

5. Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer;Acta Biochimica et Biophysica Sinica;2023-08-01